Active, not recruitingPhase 2NCT02125786
A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
Studying Ependymoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Jude Children's Research Hospital
- Principal Investigator
- Thomas E. Merchant, DO, PhDSt. Jude Children's Research Hospital
- Intervention
- Irradiation(radiation)
- Enrollment
- 68 target
- Eligibility
- 1-21 years · All sexes
- Timeline
- 2014 – 2028
Study locations (1)
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02125786 on ClinicalTrials.govOther trials for Ependymoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE1NCT04903080HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With EpendymomaChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE2NCT04743661131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaPediatric Brain Tumor Consortium
- RECRUITINGPHASE1NCT05106296Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTheodore S. Johnson
- RECRUITINGNCT05151718Multiomic Approach to Radioresistance of Ependymomas in Children and AdolescentsInstitut Claudius Regaud
- ACTIVE NOT RECRUITINGPHASE1NCT04661384Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or MedulloblastomaCity of Hope Medical Center
- ACTIVE NOT RECRUITINGPHASE1NCT02774421Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent EpendymomaUniversity of Colorado, Denver
- RECRUITINGPHASE2, PHASE3NCT02265770An International Clinical Program for the Diagnosis and Treatment of Children With EpendymomaCentre Leon Berard
- ACTIVE NOT RECRUITINGNCT00683319Observing Young Patients With Ependymoma Undergoing Standard Combination ChemotherapyChildren's Cancer and Leukaemia Group